scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.TIPS.2015.11.005 |
P8608 | Fatcat ID | release_dx7uqqjdxzfnpprqjcvj4n7mby |
P698 | PubMed publication ID | 26687297 |
P50 | author | Tod Cooperman | Q61796717 |
Erin R. Fox | Q91934153 | ||
P2093 | author name string | Roger Bate | |
Harry M Lever | |||
Dinesh Thakur | |||
Aparna Mathur | |||
Joe Graedon | |||
Preston Mason | |||
P433 | issue | 3 | |
P304 | page(s) | 184-191 | |
P577 | publication date | 2015-12-12 | |
P1433 | published in | Trends in Pharmacological Sciences | Q2451474 |
P1476 | title | Generics Substitution, Bioequivalence Standards, and International Oversight: Complex Issues Facing the FDA | |
P478 | volume | 37 |
Q90521688 | Barriers to Oncology Biosimilars Uptake in the United States |
Q93263281 | Bioequivalence and Therapeutic Equivalence of Generic and Brand Bupropion in Adults With Major Depression: A Randomized Clinical Trial |
Q37334533 | Evaluation of pharmaceutical concerns in Germany: frequency and potential reasons |
Q49720626 | Generic Substitution of Orphan Drugs for the Treatment of Rare Diseases: Exploring the Potential Challenges |
Q94582722 | Stereoselective steady-state disposition and bioequivalence of brand and generic bupropion in adults |
Q37322523 | Use of population approach non-linear mixed effects models in the evaluation of biosimilarity of monoclonal antibodies. |
Search more.